DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / M•••••••••
D• H••••••••• P••••••• Announces Sale of M••••••••• to D••••• P••••••••• P••
Exit to a strategic buyerannouncedannounced Aug 30, 2022Fact
What happened
- Target
- M•••••••••
- Platform
- not an add-on on record
- Control
- unknown
- Share acquired
- unknown
- Industry
- healthcare / healthcare, pharma, veterinar
- Target location
- unknown
- Seller kind
- Sponsor
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
5 named
Buy side
- “D• H••••••••• P••••••• Announces Sale of M••••••••• to D••••• P••••••••• P••”
- ““The speed at which the Company improved operationally over the last couple of years was the highlight of our investment” said E••• M••••, Principal at DWHP.”
Sell side
- “D• H••••••••• P••••••• is a private equity firm focused exclusively on the healthcare industry.”
Advisory side
- S•••••Sell-side adviserconfirmed“S••••• acted as exclusive financial advisor to M••••••••• for the transaction.”
Side not stated
- “D• H••••••••• P••••••• Announces Sale of M••••••••• to D••••• P••••••••• P••”
Evidence
“D• H••••••••• P••••••• Announces Sale of M••••••••• to D••••• P••••••••• P••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026